ClinicalTrials.Veeva

Menu

Safety Study of Shenmai(a Chinese Medicine Injection) Used in Hospitals in China

C

China Academy of Chinese Medical Sciences

Status

Unknown

Conditions

Shock
Coronary Heart Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01612611
RSCMI-Ⅵ

Details and patient eligibility

About

The purpose of this study is to make a cohort event monitoring to see whether and how Shenmai injection in hospital results in adverse events or adverse drug reactions.

Full description

Safety surveillance on Chinese Medicine injection is an important problem that needs to be sorted out ,because in mainland China hospitals ,Chinese Medicine Injection are used widely. Population for taking medicine characteristics,the incidence rate of ADR and other uncertain factors influence can not be found now.

A registry study for shenmai injection safety surveillance with 30000 patients will be conducted from Jan.2012 to Dec.2015.

Eligibility criteria Patients who will use shenmai injection in selected hospitals.

Enrollment

30,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all inpatients use Shenmai injection in 30 selected hospitals during their hospital stay

Exclusion criteria

  • none

Trial design

30,000 participants in 1 patient group

a cohort using Shenmai injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems